Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial.

J Prev Alzheimers Dis · 2024 · PMC11266258 · PMID 39044496

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

The analyses also identified individuals who had a family history of Alzheimer's disease and individuals who were APOE ε4 carriers as having a decreased odds of trial dropout of 25% and 21% respectively; though these associations were only marginally significant.

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.